- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
Sinae Iguratimod fabrica, supplementum, Factory
Jiangsu Run'an Pharmaceutical Co, Ltd., subsidiaria omnino possessa de Jiangsu Chiatai Qingjiang Pharmaceutical Co, Ltd., modernus summus tech pharmaceuticus societas specialis in R&D, productionis et venditio fertilitatis ordinandae medicinae et varietatis APIs. Project constructionem mense Novembri 2018 incepit, LIX mu aream obtegens, cum tota obsidione 160 decies Yuan et tota area aedificium 25000 quadratum metrorum.
Praecipua activum medicamentum pharmaceuticum (API) producta: Hydrochloridem Gemcitabinum, Celecoxib, bromhexinum hydrochloridum, Iguratimod, Apremilast, Citrate Tofactinib, Crisaborole, Urapidil Hydrochloride, Sugammadex Natrium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium Bromidum, Finerenone, etc. elit mundi genus facti et productorum gignentium opificem per constantem emendationem et innovationem in technologiarum, et occasiones praeclarum negotium praebent sodalibus nostris per orbem terrarum. Munus nostrum ad praestantes operas emptores nobis permisit ut solidas relationes cum sociis nostris toto orbe extunderet.
- View as
![N-(3-Formamido-4-oxo-6-phénoxy-4H-chromen-7-yl) methanesulfonamide N-[7-(Methanesulfonamido) -4-oxo-6-phenoxy-4H-chromen-3-yl]](/upload/7632/n-3-formamido-4-oxo-6-phenoxy-4h-chromen-7-yl-methanesulfonamide-n-7-methanesulfonamido-4-oxo-6-phenoxy-4h-chromen-3-yl-formamide_550783.jpg "N-(3-Formamido-4-oxo-6-phénoxy-4H-chromen-7-yl) methanesulfonamide N-[7-(Methanesulfonamido) -4-oxo-6-phenoxy-4H-chromen-3-yl]")
N-(3-Formamido-4-oxo-6-phénoxy-4H-chromen-7-yl) methanesulfonamide N-[7-(Methanesulfonamido) -4-oxo-6-phenoxy-4H-chromen-3-yl]
Seres operis nomen: Ellamod
Sinensis alias: N-(3-Formamido-4-oxo-6-phenoxy-4H-chromen-7-yl) methanesulfonamide N-[7-(Methanesulfonamido) -4-oxo-6-phenoxy-4H-chromen-3- y] formamide
Anglicus operis nomen: Iguratimod
CAS#123663-49-0
Formulae hypotheticae: C17H14N2O6S
Pondus hypotheticum: 374.3679
Species et possessiones: cerussa
Adnotationis domesticae numerus API: Y20190021542
Iguratimod API
Seres operis nomen: Ellamod
Sinensis alias: N-[3-(carboxamido)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide
Anglicus operis nomen: Iguratimod
Cas#123663-49-0
Formulae hypotheticae: C17H14N2O6S
Pondus hypotheticum: 374.3679
Species et possessiones: cerussa
Adnotationis domesticae numerus API: Y20190021542
Iguratimod API medicamento anti-rheumatico, synovitis medicamento.
Quiescere potes ex officina nostra emere Iguratimod in Sinis. Pharmaceutical Run'an professionalis Sinarum Iguratimod fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.
